The UK’s data protection regulator, the Information Commissioner’s Office (‘ICO’), has released draft guidance on the research provisions within the UK’s General Data Protection Regulation (‘UK GDPR’) and Data Protection Act (‘DPA’). The guidance is out for public consultation until 22 April 2022.
Continue Reading What does the ICO tell us about using data for research purposes?

As currently drafted, the California Consumer Privacy Act (“CCPA”) leaves many questions unresolved regarding how the law applies to data collected and used in the health care and life sciences industries, particularly in the research context. Clinical research sponsors and other industry participants have raised concerns about how the CCPA may impede care delivery and

Despite intensive lobbying from industry groups, multiple amendments before its effective date, and extensive proposed regulations from the California attorney general, the California Consumer Privacy Act (CCPA) went into effect earlier this month with still many questions left unanswered:

Continue Reading Proposed CCPA amendment would provide significant clarity to health care and life sciences companies

This week the EU’s independent data protection authority (DPA), the European Data Protection Supervisor (EDPS), published a preliminary opinion on data protection and scientific research subject to the General Data Protection Regulation 679/2016 (GDPR) and Regulation 1725/2018 governing data protection in EU institutions (Preliminary Opinion). Regulation 1725/2018 is very similar to the GDPR’s provisions in this area, and the EDPS states that the Preliminary Opinion may be regarded as relevant to data processing under both regulations.

The Preliminary Opinion builds on the work of the European Data Protection Board (EDPB) in promoting a dialogue between DPAs, ethical review boards and organisations conducting scientific research. Continue Reading EDPS, data protection and scientific research